Skip to content

Study · Not a test of the peptide alone · 2000

3 results

[Applications of immunomodulators in complex of treatment of the soft tissue purulent wounds].

Potiĭ VV

Klinichna khirurhiia1 Oct 2000Cited by 1 (Europe PMC)

PMID11247420 (opens in a new tab)PepBankPUB-11247420
Publisher pageAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, Thymogen (oglufanide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymogen (oglufanide).

  1. 01HumanNot a test of Thymogen (oglufanide) aloneNon-randomized trialEfficacy outcome

    In patients with purulent soft-tissue wounds, the thymogen, sillard and Echinacea regimen was associated with more rapid wound cleansing.

    In plain wordsIn patients with purulent wounds, the regimen containing thymogen was associated with faster wound cleansing.

    Peptide
    Thymogen (oglufanide)
    Outcome
    IncreaseWound cleansing
    Study

    n = 31

    Outcome group
    Wound healing · Skin and wound

    Source sentences

    Summary
    In 31 patients with purulent wound of soft tissues more rapid cleansing and healing of the wound, the immunity indexes normalization were noted
    1 context sentence
    Summary · context
    while application of immunomodulator thymogen in combination with the siliceous sorbent sillard application and adaptogenic preparation--tincture of Echinacea Purpurea.

    In this study, Thymogen (oglufanide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymogen (oglufanide).

  2. 02HumanNot a test of Thymogen (oglufanide) aloneNon-randomized trialEfficacy outcome

    In patients with purulent soft-tissue wounds, the thymogen, sillard and Echinacea regimen was associated with more rapid wound healing.

    In plain wordsIn patients with purulent wounds, the regimen containing thymogen was associated with faster wound healing.

    Peptide
    Thymogen (oglufanide)
    Outcome
    IncreaseWound healing
    Study

    n = 31

    Outcome group
    Wound healing · Skin and wound

    Source sentences

    Summary
    In 31 patients with purulent wound of soft tissues more rapid cleansing and healing of the wound, the immunity indexes normalization were noted
    1 context sentence
    Summary · context
    while application of immunomodulator thymogen in combination with the siliceous sorbent sillard application and adaptogenic preparation--tincture of Echinacea Purpurea.

    In this study, Thymogen (oglufanide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymogen (oglufanide).

  3. 03HumanNot a test of Thymogen (oglufanide) aloneNon-randomized trialEfficacy outcome

    In patients with purulent soft-tissue wounds, the thymogen, sillard and Echinacea regimen was associated with normalized immune indexes.

    In plain wordsIn patients with purulent wounds, the regimen containing thymogen was linked to normalized immune measures.

    Peptide
    Thymogen (oglufanide)
    Outcome
    Not applicableImmune index normalization
    Study

    n = 31

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    In 31 patients with purulent wound of soft tissues more rapid cleansing and healing of the wound, the immunity indexes normalization were noted
    1 context sentence
    Summary · context
    while application of immunomodulator thymogen in combination with the siliceous sorbent sillard application and adaptogenic preparation--tincture of Echinacea Purpurea.

    In this study, Thymogen (oglufanide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymogen (oglufanide).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.